Biology Reference
In-Depth Information
20. Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta
2007;375:36-42.
21. Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, et al. Masquerader:
high mobility group box-1 and cancer. Clin Cancer Res 2007;13:2836-48.
22. Fossati S, Chiarugi A. Relevance of high-mobility group protein box 1 to neurodegenera-
tion. Int Rev Neurobiol 2007;82:137-48.
23. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, et al. The
HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008;28:12023-31.
24. Guazzi S, Strangio A, Franzi AT, Bianchi ME. HMGB1, an architectural chromatin pro-
tein and extracellular signalling factor, has a spatially and temporally restricted expression
pattern in mouse brain. Gene Expr Patterns 2003;3:29-33.
25. Enokido Y, Yoshitake A, Ito H, Okazawa H. Age-dependent change of HMGB1 and
DNA double-strand break accumulation in mouse brain. Biochem Biophys Res Commun
2008;376:128-33.
26. Kobori N, Clifton GL, Dash P. Altered expression of novel genes in the cerebral cortex
following experimental brain injury. Brain Res Mol Brain Res 2002;104:148-58.
27. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, et al. Early release of
HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab
2008;28:927-38.
28. Kim JB, Lim CM, Yu YM, Lee JK. Induction and subcellular localization of high-mobility
group box-1 (HMGB1) in the postischemic rat brain. J Neurosci Res 2008;86:1125-31.
29. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, et al. High mobil-
ity group box 1 protein is released by neural cells upon different stresses and worsens
ischemic neurodegeneration
in vitro
and
in vivo
. J Neurochem 2007;103:590-603.
30. Passalacqua M, Patrone M, Picotti GB, Del Rio M, Sparatore B, Melloni E, et al.
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuro-
blastoma cell differentiation. Neuroscience 1998;82:1021-28.
31. O'Connor KA, Hansen MK, Rachal Pugh C, Deak MM, Biedenkapp JC, Milligan ED,
et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflamma-
tory cytokine: central nervous system effects. Cytokine 2003;24:254-65.
32. Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, et al.
Pivotal advance: HMGB1 expression in active lesions of human and experimental mul-
tiple sclerosis. J Leukoc Biol 2008;84:1248-55.
33. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, et al. Anti-high mobility
group box 1 monoclonal antibody ameliorates brain infarction induced by transient isch-
emia in rats. FASEB J 2007;21:3904-16.
34. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, et al. HMGB1, a novel cytokine-
like mediator linking acute neuronal death and delayed neuroinflammation in the postisch-
emic brain. J Neurosci 2006;26:6413-21.
35. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinflammatory
activity by binding to cytokines. J Immunol 2008;180:2531-37.
36. Miller G. The dark side of glia. Science 2005;308:778-81.
37. Wunder A, Klohs J, Dirnagl U. Non-invasive visualization of CNS inflammation with
nuclear and optical imaging. Neuroscience 2009;158:1161-73.
38. Takata K, Kitamura Y, Tsuchiya D, Kawasaki T, Taniguchi T, Shimohama S. High mobil-
ity group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotox-
icity. J Neurosci Res 2004;78:880-91.
39. Bowman CC, Rasley A, Tranguch SL, Marriott I. Cultured astrocytes express toll-like
receptors for bacterial products. Glia 2003;43:281-91.
